| __timestamp | Protagonist Therapeutics, Inc. | Soleno Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 1860000 | 2917513 |
| Thursday, January 1, 2015 | 2963000 | 7878291 |
| Friday, January 1, 2016 | 6961000 | 8366794 |
| Sunday, January 1, 2017 | 11779000 | 6610381 |
| Monday, January 1, 2018 | 13697000 | 6556000 |
| Tuesday, January 1, 2019 | 15749000 | 6930000 |
| Wednesday, January 1, 2020 | 18638000 | 8758000 |
| Friday, January 1, 2021 | 27196000 | 10806000 |
| Saturday, January 1, 2022 | 31739000 | 9844000 |
| Sunday, January 1, 2023 | 33491000 | 13481000 |
In pursuit of knowledge
In the competitive landscape of biotechnology, understanding financial trends is crucial. Protagonist Therapeutics, Inc. and Soleno Therapeutics, Inc. have shown distinct trajectories in their Selling, General, and Administrative (SG&A) expenses over the past decade. From 2014 to 2023, Protagonist Therapeutics experienced a staggering 1,700% increase in SG&A expenses, peaking at approximately $33.5 million in 2023. In contrast, Soleno Therapeutics saw a more modest 360% rise, reaching around $13.5 million in the same year.
Protagonist's aggressive spending strategy, particularly post-2020, suggests a focus on scaling operations and expanding market reach. Meanwhile, Soleno's steadier growth indicates a more conservative approach, possibly prioritizing sustainable development. These trends highlight the diverse strategies within the biotech sector, offering valuable insights for investors and industry analysts alike.
Breaking Down SG&A Expenses: Novo Nordisk A/S vs Soleno Therapeutics, Inc.
Selling, General, and Administrative Costs: AbbVie Inc. vs Soleno Therapeutics, Inc.
Operational Costs Compared: SG&A Analysis of Amgen Inc. and Soleno Therapeutics, Inc.
Selling, General, and Administrative Costs: Regeneron Pharmaceuticals, Inc. vs Soleno Therapeutics, Inc.
Who Optimizes SG&A Costs Better? GSK plc or Protagonist Therapeutics, Inc.
Operational Costs Compared: SG&A Analysis of Catalent, Inc. and Soleno Therapeutics, Inc.
SG&A Efficiency Analysis: Comparing Opthea Limited and Protagonist Therapeutics, Inc.
Operational Costs Compared: SG&A Analysis of Verona Pharma plc and Protagonist Therapeutics, Inc.
Apellis Pharmaceuticals, Inc. or Soleno Therapeutics, Inc.: Who Manages SG&A Costs Better?
Comparing SG&A Expenses: ACADIA Pharmaceuticals Inc. vs Soleno Therapeutics, Inc. Trends and Insights
Bausch Health Companies Inc. or Soleno Therapeutics, Inc.: Who Manages SG&A Costs Better?
Amicus Therapeutics, Inc. and Soleno Therapeutics, Inc.: SG&A Spending Patterns Compared